News for Healthier Living

AACR: HER2 targeted therapy shows promise in previously treated lung cancers

* Zongertinib, a HER2-targeted therapy made by Boehringer Ingelheim, demonstrated promising results in HER2-mutant lung cancer

April 28, 2025


May 18 2025

May 17 2025

May 16 2025

May 15 2025

May 14 2025

May 13 2025

May 12 2025

May 11 2025

May 10 2025

May 9 2025

May 8 2025

May 7 2025

May 6 2025

May 5 2025